Literature DB >> 29324172

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29324172      PMCID： PMC5791564          DOI： 10.1080/21645515.2018.1419757

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

Authors:  Daniel Novakovic; Alan T L Cheng; Yvonne Zurynski; Robert Booy; Paul J Walker; Robert Berkowitz; Henley Harrison; Robert Black; Christopher Perry; Shyan Vijayasekaran; David Wabnitz; Hannah Burns; Sepehr N Tabrizi; Suzanne M Garland; Elizabeth Elliott; Julia M L Brotherton
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

2.  Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.

Authors:  Xavier Sáez-Llorens; Vianney Tricou; Delia Yu; Luis Rivera; José Jimeno; Ana Cecilia Villarreal; Epiphany Dato; Sonia Mazara; Maria Vargas; Manja Brose; Martina Rauscher; Suely Tuboi; Astrid Borkowski; Derek Wallace
Journal:  Lancet Infect Dis       Date:  2017-11-06       Impact factor: 25.071

3.  4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years.

Authors:  Daron G Ferris; Rudiwilai Samakoses; Stanley L Block; Eduardo Lazcano-Ponce; Jaime Alberto Restrepo; Jesper Mehlsen; Archana Chatterjee; Ole-Erik Iversen; Amita Joshi; Jian-Li Chu; Andrea Likos Krick; Alfred Saah; Rituparna Das
Journal:  Pediatrics       Date:  2017-12       Impact factor: 7.124

4.  PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.

Authors:  Moufida Ben Nasr; Sara Tezza; Francesca D'Addio; Chiara Mameli; Vera Usuelli; Anna Maestroni; Domenico Corradi; Silvana Belletti; Luca Albarello; Gabriella Becchi; Gian Paolo Fadini; Christian Schuetz; James Markmann; Clive Wasserfall; Leonard Zon; Gian Vincenzo Zuccotti; Paolo Fiorina
Journal:  Sci Transl Med       Date:  2017-11-15       Impact factor: 17.956

5.  Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.

Authors:  Ehsan Ghorani; Baljeet Kaur; Rosemary A Fisher; Dee Short; Ulrika Joneborg; Joseph W Carlson; Ayse Akarca; Teresa Marafioti; Sergio A Quezada; Naveed Sarwar; Michael J Seckl
Journal:  Lancet       Date:  2017-11-25       Impact factor: 79.321

6.  Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine.

Authors:  Amy Lingel; Brianna L Bullard; Eric A Weaver
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.